DBV Technologies Targets $150 Million via American Depositary Shares' Sale

12:01 AM EDT, 07/20/2026 (MT Newswires) -- DBV Technologies (DBV.PA, DBV.F) is looking to raise up to $150 million from the issuance of American Depositary Shares, or ADS, under a refreshed at-the-market offering program. The late-stage biopharmaceutical company submitted the sales agreement prospectus supplement to renew its ATM program established in September 2025, according to a July 17, 2026, release. Net proceeds from any offering of securities will be used for activities associated with manufacturing expansion, biologics license applications, the launch preparation of Viaskin Peanut, the development of product candidates, and for working capital and other general corporate purposes.